Form 483

Ionetix Corporation Form 483, 2026-04-02

FDA issued a Form 483 to Ionetix Corporation on 2026-04-02 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Ionetix Corporation · Sarasota, United States · Issued April 2, 2026

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Apr 2026
21 CFR 212.20(c)

Specifications and processes

Cited by Joanne E King

2 Apr 2026
21 CFR 212.30(b)

Equipment procedures

Cited by Joanne E King

2 Apr 2026
21 CFR 212.40(c)

Use of reliable suppliers

Cited by Joanne E King

2 Apr 2026
21 CFR 212.50(a)

Written control procedures

Cited by Joanne E King

Inspected site

ICIonetix CorporationSarasota, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.20(c)Cited across public-safe Form 483 observations1x
21 CFR 212.30(b)Cited across public-safe Form 483 observations1x
21 CFR 212.40(c)Cited across public-safe Form 483 observations1x
21 CFR 212.50(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere